Spiration Valves Against Standard Therapy

Stopped early · Not applicable

Conditions studied: Pulmonary Air Leaks

In brief

VAST is a multicenter, prospective, randomized, controlled study designed to evaluate treatment of persistent air leak with the SVS as compared to standard chest tube drainage management and other standard-of-care interventions in the control group. Eligible subjects will be randomized to receive either Spiration Valves (investigational arm) or continue standard-of-care treatment (control arm). Once the air leak has resolved, Spiration Valves should be removed.

Key facts

Study ID
NCT02382614
Run by
Olympus Corporation of the Americas
People needed
75
Starts
2015-05-01
Expected to finish
2022-02-01
Last updated by the study team
2024-04-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.